Published

Question-based Drug Development for psilocybin.

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: The lancet. Psychiatry
Date: 2016-09-01
Source: PubMed
DOI: 10.1016/s2215-0366(16)30214-0
PubMed: 27568265

Authors

Dijkstra FM Jacobs GE Cohen AF

Watch author

Derived topics and classifications

psilocybin General Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Question-based Drug Development for psilocybin.2016-09-01

Related papers

A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in VeteransClinicalTrials.gov · 2026-08-14 Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive UseJournal of Advances in Developmental Research · 2026-06-17 Counselors’ attitudes toward psychedelics and their use in therapyJournal of Counseling & Development · 2022-03-19 Selling the Priceless Mushroom: A History of Psilocybin Mushroom Trade in the Sierra Mazateca (Oaxaca)Journal of Illicit Economies and Development · 2022-01-01 Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative reviewResearch Society and Development · 2021-08-19 POTENCIAL USO DA PSILOCIBINA NO TRATAMENTO DA DEPRESSÃO: UMA REVISÃO / POTENTIAL USE OF PSILOCYBIN IN THE DEPRESSION TREATMENT: A REVIEWBrazilian Journal of Development · 2021-01-01 Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/PsilocinClinical Pharmacology in Drug Development · 2021-01-01 The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov.Drug design, development and therapy · 2024-01-01